Isolated delta-storage pool disease

Isolated delta-storage pool disease (also known as isolated delta-storage pool deficiency or δ-SPD) is a rare inherited platelet disorder characterized by a deficiency or absence of platelet dense granules (also called delta granules). Dense granules normally store small molecules such as adenosine diphosphate (ADP), adenosine triphosphate (ATP), serotonin, and calcium, which are essential for normal platelet aggregation and the amplification of the clotting response. When these granules are deficient, platelets cannot aggregate properly, leading to a mild to moderate bleeding tendency. The primary body system affected is the hematologic (blood) system. Key clinical features include easy bruising, prolonged bleeding after surgery or dental procedures, mucocutaneous bleeding such as epistaxis (nosebleeds), menorrhagia (heavy menstrual bleeding) in women, and excessive bleeding from minor cuts or trauma. Platelet counts are typically normal, but platelet function testing reveals impaired aggregation responses, particularly to collagen and ADP. The diagnosis is confirmed by demonstrating reduced numbers of dense granules using electron microscopy or by measuring decreased levels of dense granule contents. The term 'isolated' distinguishes this condition from delta-storage pool deficiency that occurs as part of syndromic disorders such as Hermansky-Pudlak syndrome, Chediak-Higashi syndrome, or Wiskott-Aldrich syndrome, in which dense granule deficiency is accompanied by other systemic features. Treatment is primarily supportive and includes the use of desmopressin (DDAVP) to enhance platelet function, antifibrinolytic agents such as tranexamic acid or aminocaproic acid, and platelet transfusions for severe bleeding episodes or prior to major surgical procedures. Avoidance of antiplatelet medications such as aspirin and nonsteroidal anti-inflammatory drugs is recommended.

Common questions about Isolated delta-storage pool disease